Juan Li (Li Juan)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Multiple Myeloma

Top Venues

Annals of hematology

Annals of medicine

Medical oncology (Northwood, London, England)

Integrative cancer therapies

This page only lists publications with an associated author ORCID identifier.

Publications

Huihui Zhu, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Beihui Huang, Waiyi Zou, Juan Li
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma. British journal of haematology 204 (3) (2024)
Huihui Zhu, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Beihui Huang, Waiyi Zou, Juan Li
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma. British journal of haematology 204 (3) (2024)
Huihui Zhu, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Beihui Huang, Waiyi Zou, Juan Li
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma. British journal of haematology (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology 103 (5) (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology 103 (5) (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology 103 (5) (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology 103 (5) (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology 103 (5) (2024)
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-Yi Zou, Juan Li
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology 103 (5) (2024)
Yanjuan Li, Junru Liu, Beihui Huang, Meilan Chen, Jingli Gu, Juan Li
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience. Annals of medicine 55 (2) (2023)
Yanjuan Li, Junru Liu, Beihui Huang, Meilan Chen, Jingli Gu, Juan Li
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience. Annals of medicine 55 (2) (2023)
Yanjuan Li, Junru Liu, Beihui Huang, Meilan Chen, Jingli Gu, Juan Li
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience. Annals of medicine 55 (2) (2023)
Meilan Chen, Junru Liu, Xiaohong Wang, Xian Cao, Xin Gao, Lingjie Xu, Wang Liu, Jingnan Pi, Bin Wang, Juan Li
Diagnosis for Chinese patients with light chain amyloidosis: a scoping review. Annals of medicine 55 (1) (2023)
Beihui Huang, Huixin Liu, Szehoi Chan, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Xiaozhe Li, Xingding Zhang, Juan Li
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells. Medical oncology (Northwood, London, England) 40 (4) (2023)
Yanjuan Li, Junru Liu, Beihui Huang, Meilan Chen, Jingli Gu, Juan Li
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience. Annals of medicine 55 (2) (2023)
Beihui Huang, Huixin Liu, Szehoi Chan, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Xiaozhe Li, Xingding Zhang, Juan Li
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells. Medical oncology (Northwood, London, England) 40 (4) (2023)
Beihui Huang, Huixin Liu, Szehoi Chan, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Xiaozhe Li, Xingding Zhang, Juan Li
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells. Medical oncology (Northwood, London, England) 40 (4) (2023)
Yanjuan Li, Junru Liu, Beihui Huang, Meilan Chen, Jingli Gu, Juan Li
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience. Annals of medicine 55 (2) (2023)
Huixing Zhou, Yuan Jian, Juan Du, Junru Liu, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Wenming Chen, Weijun Fu, Juan Li, Wen Gao
Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era. Cancer medicine (2023)
Beihui Huang, Huixin Liu, Szehoi Chan, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang, Xiaozhe Li, Xingding Zhang, Juan Li
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells. Medical oncology (Northwood, London, England) 40 (4) (2023)
Li Xiaozhe, Chen Meilan, Huang Beihui, Liu Junru, Gu Jingli, Kuang Lifen, Juan Li
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study. Integrative cancer therapies 21 (2022)
Li Xiaozhe, Chen Meilan, Huang Beihui, Liu Junru, Gu Jingli, Kuang Lifen, Juan Li
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study. Integrative cancer therapies 21 (2022)
Li Xiaozhe, Chen Meilan, Huang Beihui, Liu Junru, Gu Jingli, Kuang Lifen, Juan Li
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study. Integrative cancer therapies 21 (2022)
Li Xiaozhe, Chen Meilan, Huang Beihui, Liu Junru, Gu Jingli, Kuang Lifen, Juan Li
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study. Integrative cancer therapies 21 (2022)
Han-Ying Huang, Yun Wang, Wei-da Wang, Xiao-Li Wei, Robert Peter Gale, Jin-Yuan Li, Qian-Yi Zhang, Ling-Ling Shu, Liang Li, Juan Li, Huan-Xin Lin, Zhi-Wei Liang
A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma. Leukemia 35 (11) (2021)
Qianying Pan, Juan Li
Efficacy and safety of cladribine addition to induction treatment of newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Xiaozhe Li, Beihui Huang, Junru Liu, Meilan Chen, Jingli Gu, Juan Li
Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis. Journal of cancer research and clinical oncology (2021)
Limei Xu, Junru Liu, Meilan Chen, Lifen Kuang, Beihui Huang, Jingli Gu, Juan Li
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma. Annals of hematology 99 (3) (2020)
Xiaozhe Li, Junru Liu, Meilan Chen, Jingli Gu, Beihui Huang, Dong Zheng, Juan Li
Health-related quality of life of patients with multiple myeloma: A real-world study in China. Cancer medicine 9 (21) (2020)
Wen Gao, Yuan Jian, Juan Du, Xiaozhe Li, Huixing Zhou, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Weijun Fu, Juan Li, Wenming Chen
Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China. Cancer medicine 9 (21) (2020)
Xiaozhe Li, Wenming Chen, Yin Wu, Jianyong Li, Lijuan Chen, Baijun Fang, Ying Feng, Junru Liu, Meilan Chen, Jingli Gu, Beihui Huang, Juan Li
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China. The oncologist 24 (11) (2019)